Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Thoma Bravo to take Dayforce private

Reuters on MSN · 21h
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
By Milana Vinn (Reuters) -Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
The Wall Street Journal on MSN · 1d
Thoma Bravo to Buy Dayforce for $11.2 Billion
Dayforce has agreed to be acquired by private-equity firm Thoma Bravo in a deal that values the provider of human-resources software at around $11.2 billion.
Benzinga · 3h
Dayforce, Thoma Bravo Deal Has Some Analysts Wanting More
Dayforce agreed to a take-private deal with Thoma Bravo on Thursday, and two analysts promptly downgraded the stock.
3d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...
1don MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...
4don MSN

A buyout firm reportedly has Dayforce in its sights. Shares of the HR software group are soaring.

Buyout firm Thoma Bravo could announce a deal in the next few weeks to take Dayforce private, Bloomberg reported on Monday, citing sources.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy